Market Research Report
Anaesthesia Devices - World - 2021
|Anaesthesia Devices - World - 2021|
Published: November 19, 2021
Content info: 102 Pages
Delivery time: 1-2 business days
A highly detailed, 102 page, data-centric analysis of the world market for anaesthesia devices with competitor market share analysis.
The world market for ventilators, comprising Low-End Anaesthesia Devices, Mid-Range Anaesthesia Devices, High-End Anaesthesia Devices, and Premium Anaesthesia Devices, is estimated to have been worth $973M in 2020. It is forecast to increase at a CAGR of 1.9% to $1.1B in 2025, according to a new report from Signify Research, an independent supplier of market intelligence and consultancy to the global healthcare technology industry.
The COVID-19 pandemic had a significant impact on demand for clinical information systems globally. With a significant number of countries in lockdown in Q2 and Q3 of 2020, admission to hospital for non-elective or less critical procedures were placed on hold. Consequently, the demand for anaesthesia solutions to be utilised in surgeries was much lower in 2020 in those countries that were most impacted by the pandemic. In some countries, the 'off-label' usage of anaesthesia devices as a mechanical ventilator was granted. This resulted in a temporary uplift in demand for solutions where ventilator supply was most restricted.
Fastest revenue growth overall is projected for Low-end anaesthesia devices; these solutions offer basic levels of care in emerging regions at lower costs. However, with increasing demand for solutions that help to optimise patient care provision and offer a higher level of functionality, most revenue growth is projected for premium solutions. Mid-range devices will remain the largest segment through to 2025; these solutions offer a reasonable level of functionality at an affordable price; as cost efficiency is likely to be prioritised, Mid-range solutions offer this flexibility.
The US market is relatively saturated; demand was maintained during the pandemic despite a reduction in surgeries performed. Revenues are projected to decline in 2021 with a rebound in 2022. Western Europe saw the largest uplift in anaesthesia devices for use during the pandemic. Subsequent decline is projected in 2021 resulting in a negative average annual growth through to 2025. However, revenues will remain above 2019 levels through to 2025. Fastest revenue growth is projected for the Asia Pacific market; China and India markets are maintaining growth in the region through healthcare reform specifically targeted to improve care provision to a wider patient population.